Can Robust Invisalign Momentum Drive Align Technology's Q2 Earnings?
The company posted adjusted earnings per share (EPS) of $2.13 in the last reported quarter, which topped the Zacks Consensus Estimate by 7.6%. Align Technology beat on earnings in each of the trailing four quarters, the average surprise being 3.40%.
ALGN's Q2 Estimates
The Zacks Consensus Estimate for revenues is pegged at $1.06 billion, which suggests a rise of 3.2% from the year-ago reported figure.
The Zacks Consensus Estimate for earnings is pinned at $2.57 per share, which implies a 6.6% rise from the year-ago recorded actuals.
Estimate Revision Trend Ahead of ALGN's Q2 Earnings
Estimates for second-quarter earnings have remained unchanged at $2.57 per share in the past 30 days.
Let's take a look at how things might have shaped up for the MedTech major prior to the announcement.
Factors at Play
Clear Aligner Business
Similar to the last reported quarter, Align Technology is likely to have witnessed strength in Clear Aligner volumes for teens and adult patient, reflecting growth across regions, especially APAC and EMEA. Growth in the APAC and EMEA regions is likely to have been driven the orthodontic and GP dentist channels across teens, kids and adult patients. Meanwhile, we expect Clear Aligner volume growth in in North America to have persisted in the to-be-reported quarter, driven by growth in Invisalign DSP touch-up cases, Invisalign Palate Expander system, as well as Invisalign Comprehensive Three and Three.
In the first quarter, Clear Aligner volume from DSO customers increased year over year, reflecting growth across all regions. The DSO business in the United States continued to outpace the retail doctors, driven by the company's largest DSO partners — SmileDoctors and Heartland Dental. This might have benefited the company's quarterly top line.
In the second quarter, its Invisalign Palatal Expander System received approval from the National Medical Products Administration ('NMPA') in China. Additionally, Align Technology introduced the Invisalign System with mandibular advancement featuring occlusal blocks. It is designed to address Class II skeletal and dental correction by simultaneously advancing the mandible while aligning the teeth. The system is commercially available in the United States, Canada, Australia and New Zealand. These factors, too, might have aided Align Technology's second-quarter revenues.
Align Technology, Inc. Price and EPS Surprise
Align Technology, Inc. price-eps-surprise | Align Technology, Inc. Quote
Imaging Systems & CAD/CAM Service Business
The Systems & Services business is projected to have witnessed growth in the second quarter due to increased scanner volumes and non-system revenues driven by iTero Lumina wand upgrades. The continuous uptake of the iTero Lumina Scanner with ortho workflow and positive response from customers are likely to have boosted the company's revenues.
In the previous quarter, Align Technology launched its next-generation iTero Lumina solutions with comprehensive capabilities, including the Near Infra-Red Imaging technology in the iTero Lumina Pro dental imaging system. Also, it launched Align X-ray Insights — a new software-based computer-aided detection solution that uses artificial intelligence (AI) to automatically analyze 2D radiographs — in the EU countries and the United Kingdom. We expect these developments to have positively impacted the company's second-quarter top line.
What Our Quantitative Model Predicts for ALGN
Per our proven model, stocks with a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold), along with a positive Earnings ESP, have a higher chance of beating estimates. However, that is not the case here, as you can see below:
Earnings ESP: Align Technologies has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
Zacks Rank: The company currently carries a Zacks Rank #2.
Stocks Worth a Look
Here are some medical stocks worth considering, as these have the right combination of elements to post an earnings beat this reporting cycle:
CVS Health CVS has an Earnings ESP of +2.06% and a Zacks Rank #2 at present. The company is slated to release second-quarter 2025 results on July 31. You can see the complete list of today's Zacks #1 Rank stocks here.
CVS' earnings surpassed estimates in each of the trailing four quarters, the average surprise being 18.08%. The Zacks Consensus Estimate for second-quarter EPS implies a year-over-year decline of 19.7%.
Cencora COR has an Earnings ESP of +1.49% and a Zacks Rank #2 at present. The company is slated to release third-quarter fiscal 2025 results on Aug. 6.
The company's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 6.00%. The Zacks Consensus Estimate for fiscal third-quarter EPS implies a year-over-year increase of 13.2%.
Cardinal Health CAH has an Earnings ESP of +0.68% and a Zacks Rank #2 at present. The company is expected to release fiscal fourth-quarter 2025 results on Aug. 12.
CAH's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 10.30%. The Zacks Consensus Estimate for fiscal fourth-quarter EPS suggests a year-over-year improvement of 1.3%.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Align Technology, Inc. (ALGN): Free Stock Analysis Report
Cardinal Health, Inc. (CAH): Free Stock Analysis Report
CVS Health Corporation (CVS): Free Stock Analysis Report
Cencora, Inc. (COR): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Earnings Summary on Avient
Key Points Earnings per share (Non-GAAP) of $0.80 for Q2 2025 exceeded consensus estimates and rising 5%, while Revenue (GAAP) reached $866.5 million, up 2% year over year, including a 1% favorable impact from foreign exchange. operating income for this segment declined year over year These 10 stocks could mint the next wave of millionaires › Avient (NYSE:AVNT), a global provider of specialty polymer materials and solutions, reported results on August 1, 2025. Adjusted earnings per share (Non-GAAP) were $0.80, topping analyst expectations of $0.78 (non-GAAP). Revenue (GAAP) also beat estimates at $866.5 million, up from $849.7 million (GAAP) in Q2 2024. Avient's results marked its fifth straight quarter of organic revenue growth and included expanding adjusted EBITDA margins, solid cash generation, and continued progress on debt reduction. Management described the overall quarter as one with steady gains in high-margin segments, though with pockets of ongoing softness in key North American markets. Metric Q2 2025 Q2 2025 Estimate Q2 2024 Y/Y Change EPS (Non-GAAP) $0.80 $0.78 $0.76 5.3% EPS (GAAP) $0.57 $0.36 58.3 Revenue $866.5 million $852.87 million $849.7 million 2.0% Adjusted EBITDA Margin 17.2% 16.9% 0.3 pp Operating Income $96.1 million $72.5 million 32.6% Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Business Overview and Recent Focus Avient operates in the specialty materials industry, supplying polymers, colorants, additives, and engineered thermoplastics. Its key end markets include packaging, healthcare (like medical device materials), defense, transportation, consumer goods, and energy. Innovation is central to Avient's approach. In 2024, it invested $98.7 million in research and development, supporting a technical workforce of around 1,100 employees, including more than 100 with doctoral degrees. The company's recent business focus has centered around expanding high-value applications and maintaining operational agility. Key priorities include strengthening its role in healthcare, defense, and sustainable materials, alongside ongoing cost control and productivity efforts. Avient considers its global manufacturing footprint and customer partnerships essential for winning new business and managing shifting regulations, tariffs, and supply chains. Quarterly Highlights: Performance and Trends During the period, Avient modestly exceeded both revenue and adjusted earnings per share expectations, with revenue (GAAP) of $866.5 million and adjusted EPS (non-GAAP) of $0.80 both surpassing analyst estimates. Net income attributable to shareholders (GAAP) was $52.6 million, up from $33.6 million (GAAP) in Q2 2024. Adjusted net income was $73.5 million, compared to $70.2 million in Q2 2024. Adjusted EBITDA was $148.9 million, boosting the associated adjusted EBITDA margin to 17.2%, an improvement of 0.3 percentage points in adjusted EBITDA margin. These gains came despite continued weak demand in sectors such as North American consumer and transportation markets. Avient's Color, Additives and Inks family, which produces specialty color and additive products for a range of everyday finished goods, reported sales of $538.6 million, down slightly from the prior year period. Despite this, the segment lifted operating income to $90.3 million Management credited this to resilient packaging demand, including double-digit growth in personal care applications in the first quarter and solid beverage packaging sales worldwide, particularly in Asia and Latin America. The Specialty Engineered Materials product family, which includes specialized plastics and additives for demanding applications such as medical supplies, new energy vehicles, and defense gear, posted a 7% rise in sales to $329.7 million compared to Q2 2024. However, operating income in the Specialty Engineered Materials group declined 6.1% to $40.2 million compared to Q2 2024, reflecting pressure on segment margins. Notably, Avient highlighted double-digit sales growth in defense (which involves protective solutions for law enforcement and armed forces) and healthcare, where products are used in medical devices and consumables. While defense and healthcare offset much of the consumer and transportation weakness, those latter end-markets saw declines in the US and Canada, but growth in EMEA and Latin America. Cost discipline and operational improvements were also themes this quarter. Avient used cash flow from operations ($113 million) to pay down $50 million in debt. This keeps the company on track for its 2025 debt reduction target of $100–$200 million. Adjusted gross margin ticked slightly lower compared to Q2 2024, but the company expanded its adjusted operating margin to 11.9%, underscoring management's attention to productivity and cost management. The period also included notable one-time items. Year-to-date net income dropped on a GAAP basis due to a significant $86.3 million impairment charge linked to a cloud-based enterprise system. Management excluded this charge from adjusted earnings, but it impacted cash and reported net income. Looking Forward: Guidance and Areas to Monitor For the third quarter, Avient forecasts adjusted EPS of $0.70 For fiscal 2025, it narrowed full-year guidance to adjusted EPS of $2.77–$2.87, narrowed from a prior range of $2.70–$2.94. The outlook for adjusted EBITDA was updated to $545–$560 million. Management expects continued margin expansion from its higher-profit sectors—especially defense and healthcare—and affirms its commitment to cost control and further debt reduction. Order book visibility remains low (about 20–30 days out), and management stated, "we expect similar demand trends that we experienced in the first half." Several items will merit close attention in future quarters. Avient is counting on continued resilience in healthcare and defense end-markets, but a significant part of its targeted second-half 2025 earnings relies on further cost savings and foreign currency gains, rather than direct sales growth. Working capital requirements rose, partly from seasonal patterns and incentive payouts, so cash management will be important to watch. Raw material cost inflation is expected to be limited to 1–2% for the year. The company also reported that fewer than 3% of sales and 8% of raw material costs are exposed to tariff risks, due to a focus on local manufacturing, as disclosed by management in May. Overall, the business is positioned to benefit from its innovation, global reach, and a diversified customer base, while keeping a close eye on shifting demand in its core North American consumer and transportation markets. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,036%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. *Stock Advisor returns as of July 29, 2025 JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Globe and Mail
2 hours ago
- Globe and Mail
Gran Tierra Energy Reports Record Production in Q2 2025
Gran Tierra Energy Inc ( (GTE)) has released its Q2 earnings. Here is a breakdown of the information Gran Tierra Energy Inc presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Gran Tierra Energy Inc. is an independent international energy company focused on oil and natural gas exploration and production, with operations primarily in Canada, Colombia, and Ecuador. The company is known for its diversified portfolio and disciplined approach to reservoir management. In its second quarter of 2025, Gran Tierra Energy Inc. reported record production levels, achieving an average of 47,196 barrels of oil equivalent per day. The company also announced a funds flow from operations of $54 million and an adjusted EBITDA of $77 million. Additionally, Gran Tierra signed a mandate letter for a $200 million funding facility and entered a binding agreement to exit the UK North Sea. Key financial highlights include a net loss of $13 million, a decrease from the previous quarter, and a 44% increase in production compared to the same quarter last year. The company achieved a record of 32 million hours without a lost time injury and reported the lowest operating costs per barrel since early 2022. Gran Tierra's strategic moves, such as successful drilling in Colombia and Canada, and exploration in Ecuador, contributed to these outcomes. Gran Tierra continues to optimize its portfolio by divesting from non-core assets, such as the UK North Sea, and focusing on its core operations in South America and Canada. The company is also enhancing its financial flexibility through strategic funding arrangements and a disciplined hedging strategy. Looking ahead, Gran Tierra Energy Inc. remains committed to its strategy of disciplined capital allocation and balanced growth, with plans for further exploration and development in its key operational areas. The management anticipates continued strong performance and long-term value generation for stakeholders.
Globe and Mail
2 hours ago
- Globe and Mail
Paramount Global Reports Strong Q2 2025 Earnings
Paramount Global ( (PARA)) has released its Q2 earnings. Here is a breakdown of the information Paramount Global presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Paramount Global is a leading global media and entertainment company known for its extensive portfolio of iconic brands, including CBS, Paramount Pictures, and Paramount+, offering a wide range of content and streaming services. In its latest earnings report for Q2 2025, Paramount Global highlighted its continued transformation into a streaming-first company, with direct-to-consumer (DTC) revenue growing by 15% year-over-year, driven by the strong performance of Paramount+. The company's total revenue increased by 1% compared to the previous year, with notable growth in affiliate and subscription revenue. Paramount+ saw a 23% increase in total revenue and a 24% rise in subscription revenue, reflecting improved watch time and reduced churn. Despite a 6% decline in TV media revenue, the company achieved significant milestones in its content offerings, with CBS maintaining its position as the most-watched broadcast network in primetime for the 17th consecutive season. Paramount Pictures also reported a successful quarter, with the global premiere of 'Mission: Impossible – The Final Reckoning' setting a franchise record for the biggest global opening. Looking ahead, Paramount Global's management remains optimistic about the company's growth prospects, emphasizing the strength of its content strategy and the ongoing expansion of its streaming services.
